See more : Kawanishi Warehouse Co.,Ltd. (9322.T) Income Statement Analysis – Financial Results
Complete financial analysis of Pure Extracts Technologies Corp. (PRXTF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Pure Extracts Technologies Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- BrainChip Holdings Ltd (BCHPY) Income Statement Analysis – Financial Results
- Biotage AB (publ) (BIOT.ST) Income Statement Analysis – Financial Results
- Canny Elevator Co., Ltd. (002367.SZ) Income Statement Analysis – Financial Results
- Chukyoiyakuhin Co.,Ltd. (4558.T) Income Statement Analysis – Financial Results
- APi Group Corporation (APG) Income Statement Analysis – Financial Results
Pure Extracts Technologies Corp. (PRXTF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://pureextractscorp.com
About Pure Extracts Technologies Corp.
Pure Extracts Technologies Corp. engages in the extraction and processing of cannabis, hemp, and functional mushrooms to produce oils and various derivative products in Canada. The company offers THC and CBD based extracted oils. It also engages in the development and commercialization of functional mushroom wellness products and psychedelic medical products. The company was formerly known as Big Sky Petroleum Corporation and change its name to Pure Extracts Technologies Corp. in October 2020. Pure Extracts Technologies Corp. is headquartered in Pemberton, Canada.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|
| Revenue | 953.99K | 82.46K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 3.01M | 8.62M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -2.06M | -8.54M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | -215.67% | -10,351.67% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 28.25K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 3.94M | 12.21M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 102.10K | 3.75M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.77M | 5.05M | 61.20K | 83.52K | 58.02K | 64.69K | 75.27K |
| Other Expenses | 39.41K | 21.37K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.73M | 5.05M | 61.20K | 83.52K | 58.02K | 64.69K | 75.27K |
| Cost & Expenses | 4.74M | 13.67M | 61.20K | 83.52K | 58.02K | 64.69K | 75.27K |
| Interest Income | 2.15K | 974.72 | 576.09 | 357.77 | 45.58 | 0.00 | 0.00 |
| Interest Expense | 115.54K | 165.84K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 582.86K | 554.47K | 206.30K | 171.86K | 161.14K | 52.52K | 22.82K |
| EBITDA | -3.20M | -13.04M | -61.21K | -83.52K | -58.02K | -64.69K | -75.27K |
| EBITDA Ratio | -335.58% | -15,809.28% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -3.78M | -13.59M | -61.21K | -83.52K | -58.02K | -64.69K | -75.27K |
| Operating Income Ratio | -396.68% | -16,481.67% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -284.45K | -3.12M | 579.00 | 355.00 | -11.92K | 197.60K | -230.29K |
| Income Before Tax | -4.07M | -16.71M | -60.63K | -83.16K | -69.93K | 132.91K | -305.56K |
| Income Before Tax Ratio | -426.50% | -20,265.10% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -4.07M | -16.71M | -60.63K | -83.16K | -69.93K | 132.91K | -305.56K |
| Net Income Ratio | -426.50% | -20,265.10% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.04 | -0.26 | -0.03 | -0.12 | -0.17 | 0.33 | -0.76 |
| EPS Diluted | -0.04 | -0.26 | -0.03 | -0.12 | -0.17 | 0.33 | -0.76 |
| Weighted Avg Shares Out | 102.79M | 64.11M | 2.07M | 685.34K | 404.51K | 404.51K | 404.51K |
| Weighted Avg Shares Out (Dil) | 102.79M | 64.11M | 2.07M | 685.34K | 404.51K | 404.51K | 404.51K |
Psyence Group to form joint venture with Pure Extracts Technologies to develop psychedelic mushroom treatments for psychological trauma
Psyence Group Inc (CSE: PSYG) is poised to form a joint venture with Canada-based Pure Extracts Technologies Corp (CSE: PULL) (OTCMKTS:PRXTF) (FRA:PUX) in a bid to develop natural psychedelic treatments for psychological trauma and mental health disorders. The pair have...
Pure Extracts Technologies Corp. Announces Listing of Warrants on the Canadian Securities Exchange Under the Symbol PULL.WT Commencing March 10, 2021
VANCOUVER, British Columbia, March 09, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (“Pure” or the “Company”) (CSE: PULL) is pleased to announce that it has received approval from the Canadian Securities Exchange (the “CSE”) to list, as a supplemental...
Pure Extracts and ShroomBloom Sign Psychedelic Mushroom Supply Letter of Intent
VANCOUVER, British Columbia, March 09, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector,...
Pure Extracts Technologies Corp. Provides Update on Base Shelf Prospectus and Deemed Exercise of Special Warrants
Not for distribution to United States newswire services or for release, publication, distribution or dissemination, directly or indirectly, in whole or in part, in or into the United States.
Pure Extracts Submits Dealer's Licence Application to Health Canada
VANCOUVER, British Columbia, March 04, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector,...
Pure Extracts Orders Over 30,000 Vape Cartridges in Preparation for Retail Distribution
VANCOUVER, British Columbia, March 03, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector,...
Pure Extracts Submits Multiple SKUs to Health Canada for Approval
VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector,...
Pure Extracts Submits Application to Health Canada for Sales License
VANCOUVER, British Columbia, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector,...
REPEAT -- Pure Extracts and Canada House Wellness Group sign agreement to distribute concentrate products through existing provincial distribution channels
VANCOUVER, British Columbia, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts”) a plant-based extraction company, focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, and Canada House...
Pure Extracts and Canada House Wellness Group sign agreement to distribute concentrate products through existing provincial distribution channels
VANCOUVER, British Columbia, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts”) a plant-based extraction company, focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, and Canada House...
Source: https://incomestatements.info
Category: Stock Reports